Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-38.23	31.67	51.28
Graham Fair Price	36.62	5.80	4.24
PEG	77.30	-0.01	< 0.005
Price/Book	69.89	0.24	0.14
Price/Cash Flow	86.71	-3.29	-24.76
Prices/Earnings	20.73	-1.19	-1.50
Price/Sales	-20.73	0.75	0.94
Price/FCF	86.71	-3.29	-24.76
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.18	0.18
Operating Margin	-30.96	0.08	0.11
ROA	-100.00	-0.01	< 0.005
ROE	-0.02	-0.05	-114.32
ROIC	< 0.005	< 0.005	-8.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.04	0.08	-56.30
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	-0.69	0.38	-45.00
EPS QOQ	-2.08	-0.93	55.29
FCF QOQ	0.95	-10.93	1045.37
Revenue QOQ	-0.53	1.00	88.97
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	22.18	11.09	-50.00
Days Sales Outstanding (DSO)	556.70	144.35	-74.07
Inventory Turnover	4.06	8.11	100.00
Debt/Capitalization	0.66	0.68	3.46
Quick Ratio	1.04	0.63	-39.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5.85	5.46	-6.68
Cash	1.13	1.15	2.03
Capex	-0.04	-0.21	-476.24
Free Cash Flow	-0.03	-0.39	-1092.67
Revenue	0.87	1.74	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.12	0.70	-37.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.42	28.17	-40.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating